BDBM404881 N-methyl-1-(4-(6-(2-(4-(2,2,2- trifluoroethoxy)pyridin-2- yl)acetamido)pyridazin-3-yl)butyl)- 1H-1,2,3-triazole-4-carboxamide::US10344025, Example 225::US11370786, Example 225

SMILES CNC(=O)c1cn(CCCCc2ccc(NC(=O)Cc3cc(OCC(F)(F)F)ccn3)nn2)nn1

InChI Key InChIKey=AUALMNZWHQWIDX-UHFFFAOYSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 404881   

TargetGlutaminase kidney isoform, mitochondrial(Human)
The University of Texas Md Anderson Cancer Center

Curated by ChEMBL
LigandPNGBDBM404881(N-methyl-1-(4-(6-(2-(4-(2,2,2- trifluoroethoxy)pyr...)
Affinity DataIC50: 49nMAssay Description:Inhibition of recombinant human GLS1 using glutamine as substrate preincubated for 10 mins followed by substrate addition and measured after 20 mins ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetGlutaminase kidney isoform, mitochondrial(Human)
The University of Texas Md Anderson Cancer Center

Curated by ChEMBL
LigandPNGBDBM404881(N-methyl-1-(4-(6-(2-(4-(2,2,2- trifluoroethoxy)pyr...)
Affinity DataIC50: 100nMAssay Description:The inhibition of purified recombinant human GAC by varying concentrations of inhibitors is assessed via a dual-coupled enzymatic assay. The glutamat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2020
Entry Details
US Patent

TargetGlutaminase kidney isoform, mitochondrial(Human)
The University of Texas Md Anderson Cancer Center

Curated by ChEMBL
LigandPNGBDBM404881(N-methyl-1-(4-(6-(2-(4-(2,2,2- trifluoroethoxy)pyr...)
Affinity DataIC50: 100nMAssay Description:The inhibition of purified recombinant human GAC by varying concentrations of inhibitors is assessed via a dual-coupled enzymatic assay. The glutamat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent